NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90)

Nurexone biologic (otcqb:nrxbf) (tsxv: nrx) (fse: j90) email format

Verified email-pattern data for Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90) is currently limited. You can still use the company insights and contact sections below.
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System. The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.

Company Details

Employees
24
Founded
-
Address
Haifa, Il
Industry
Biotechnology Research
Keywords
jobs.
HQ
Haifa
Looking for a particular NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) employee's phone or email?

Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90) Questions

Top NurExone Biologic (OTCQB:NRXBF) (TSXV: NRX) (FSE: J90) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant